Stocks Health care GNLX
NASDAQ · Health careGENELUX Corp (GNLX)
It posted a net loss of $35.6M. In fiscal 2025 capital spending exceeded operating cash flow by $26.4M. At June 30, 2026 it held $9.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about GENELUX Corp
- Net worth
- GENELUX Corp has a market value (market cap) of $87.3M at the latest share price, and shareholders' equity of $16.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $8K (0.0% year on year), with a net loss of $32.1M.
- Cash flow
- In fiscal 2025 operations used $25.3M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- GENELUX Corp's next report was expected around November 4, 2026 and is not on file with the SEC yet.
What GENELUX Corp does
GENELUX Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GNLX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $8K | -$32.1M | -$0.86 | -$26.4M |
| 2024 | $8K | -$29.9M | -$0.95 | -$21.6M |
| 2023 | $170K | -$28.3M | -$1.16 | -$21.3M |
| 2023 | $11.1M | -$5.2M | -$0.57 | -$3.6M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where GNLX ranks in Health care
Latest SEC filings
What GENELUX Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 4, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026
- June 22, 2026
- May 7, 2026
- April 29, 2026
- April 29, 2026Additional proxy material DEFA14A
- April 29, 2026Proxy statement DEF 14A
- March 19, 2026
- March 19, 2026
- March 19, 2026Annual report 10-K · period to December 31, 2025Revenue was flat at $8K versus the prior year; diluted EPS -$0.86 versus -$0.95.
Insider trades
What the people running GENELUX Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $155.7K worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 3, 2026 | Yu YongChief Scientific Officer | Sold | 668 | $1.3K |
| November 3, 2026 | Zindrick ThomasPresident and CEO | Sold | 3,089 | $6.3K |
| November 3, 2026 | Cappello JosephChief Technical Officer | Sold | 668 | $1.4K |
| August 31, 2026 | Yu YongChief Scientific Officer | Sold | 9,683 | $26.7K |
| August 31, 2026 | Zindrick ThomasPresident and CEO | Sold | 34,463 | $91.9K |
| August 31, 2026 | Cappello JosephChief Technical Officer | Sold | 10,257 | $28.1K |
| August 4, 2026 | Zindrick ThomasPresident and CEO | Sold | 3,023 | $8.9K |
| August 4, 2026 | Cappello JosephChief Technical Officer | Sold | 653 | $1.9K |
Who owns GNLX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Armistice Capital, LLC13G, passive with 1 related filers | 9.99% | November 14, 2025 |
| Aladar Szalay13G, passive | 8.2% | February 17, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 72 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Woodward Diversified Capital, LLC | 2,262,108 | +144,925 |
| Vanguard Capital Management LLC | 1,677,724 | -17,756 |
| Bleichroeder LP | 1,380,666 | 0 |
| BlackRock, Inc. | 439,602 | +33,730 |
| Geode Capital Management, LLC | 439,213 | -14,548 |
| CM Management, LLC | 400,000 | +150,000 |
| Bank of America Corp | 328,803 | +4,938 |
| Vanguard Fiduciary Trust Co | 236,344 | -15,266 |
| Flputnam Investment Management Co | 231,405 | -49,499 |
| Global Retirement Partners, LLC | 227,854 | new |
| LPL Financial LLC | 157,857 | +18,816 |
| State Street Corp | 145,850 | 0 |
| Provident Wealth Management, LLC | 144,908 | -10,762 |
| LifeSteps Financial, Inc. | 121,965 | +3,103 |
| Osaic Holdings, Inc. | 121,958 | +2,950 |
| Renaissance Technologies LLC | 105,229 | +93,029 |
| Northern Trust Corp | 89,279 | -75,177 |
| Citadel Advisors LLC | 85,481 | new |
| Morgan Stanley | 83,543 | -4,505 |
| SteelPeak Wealth, LLC | 75,895 | +15,000 |
Insiders
10 insiders reported holding 3,171,416 shares in total, about $6.1M at the last price.
| Holder | Shares |
|---|---|
| Zindrick ThomasPresident and CEO | 1,223,338 |
| Thomas JohnDirector | 501,193 |
| Cappello JosephChief Technical Officer | 317,812 |
| Pulisic MatthewChief Financial Officer | 278,906 |
| Yu YongChief Scientific Officer | 258,020 |
| Groen EricGeneral Counsel | 233,957 |
| Mirabelli MaryDirector | 102,693 |
| Tyree James LDirector | 96,483 |
| Smither John WDirector | 91,403 |
| Smalling RalphHead of Regulatory | 67,611 |
Questions about GNLX
What does GENELUX Corp do?
GENELUX Corp is a company in the Health care sector, listed on NASDAQ as GNLX. Its shares trade on NASDAQ under the ticker GNLX.
What is GENELUX Corp's net worth?
GENELUX Corp has a market value (market cap) of $87.3M at the latest share price, and shareholders' equity of $16.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is GENELUX Corp profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $35.6M.
When did GENELUX Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from November 5, 2026.
When is GENELUX Corp's next earnings report?
GENELUX Corp's next report was expected around November 4, 2026 and is not on file with the SEC yet.
Similar companies
Compare GNLX with
Follow GNLX
Get an email when GENELUX Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values GENELUX Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.